DEVELOPMENT OF A SPLICE-SWITCHING ANTISENSE OLIGONUCLEOTIDE FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY

$6,048,654FY2018Department of the ArmyDOD

Shift Pharmaceuticals Holdings, Inc

Investigators